Your browser doesn't support javascript.
loading
Daptomycin suppresses tumor migration and angiogenesis via binding to ribosomal protein S19 in humans.
Cho, Sung Min; Lee, Hwa Jung; Karuso, Peter; Kwon, Ho Jeong.
Affiliation
  • Cho SM; Chemical Genomics Global Research Laboratory, Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, Republic of Korea.
  • Lee HJ; Chemical Genomics Global Research Laboratory, Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, Republic of Korea.
  • Karuso P; Department of Molecular Sciences, Macquarie University, Sydney, NSW, Australia.
  • Kwon HJ; Chemical Genomics Global Research Laboratory, Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, Republic of Korea. kwonhj@yonsei.ac.kr.
J Antibiot (Tokyo) ; 74(10): 726-733, 2021 10.
Article in En | MEDLINE | ID: mdl-34253886

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ribosomal Proteins / Cell Movement / Daptomycin / Anti-Bacterial Agents / Neovascularization, Pathologic Limits: Humans Language: En Journal: J Antibiot (Tokyo) Year: 2021 Document type: Article Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ribosomal Proteins / Cell Movement / Daptomycin / Anti-Bacterial Agents / Neovascularization, Pathologic Limits: Humans Language: En Journal: J Antibiot (Tokyo) Year: 2021 Document type: Article Country of publication: United kingdom